This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vieillard, V.
Right arrow Articles by Autran, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieillard, V.
Right arrow Articles by Autran, B.

 Previous Article  |  Next Article 

Journal of Virology, December 1999, p. 10281-10288, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Transfer of Human CD4+ T Lymphocytes Producing Beta Interferon in Hu-PBL-SCID Mice Controls Human Immunodeficiency Virus Infection

Vincent Vieillard,1,dagger Stephane Jouveshomme,2 Nicole Leflour,2 Eric Jean-Pierre,2 Patrice Debre,2 Edward De Maeyer,1 and Brigitte Autran2,*

Equipe de Génétique des Cytokines, UMR CNRS 146, Institut Curie, Orsay,1 and Laboratoire d'Immunologie Cellulaire et Tissulaire, UMR CNRS 7627, Hopital Pitie-Salpêtrière, Paris,2 France

Received 3 March 1999/Accepted 3 September 1999

Beta interferon (IFN-beta ) exerts pleiotropic antiretroviral activities and affects many different stages of the human immunodeficiency virus (HIV) infectious cycle in IFN-treated cells. To explore whether transfer of genetically engineered human CD4+ T cells producing constitutively low amounts of IFN-beta can eradicate HIV in vivo, we developed a new Hu-PBL-SCID mouse model supporting a persistent, replicative HIV infection maintained by periodic reinoculations of activated human CD4+ T cells. Transferring human CD4+ T cells containing the IFN-beta retroviral vector drastically reduced the preexisting HIV infection and enhanced CD4+ T-cell survival and Th1 cytokine expression. Furthermore, in 40% of the Hu-PBL-SCID mice engrafted with IFN-beta -transduced CD4+ T cells, HIV-1 was undetectable in vivo as well as after cocultivation of mouse tissues with human phytohemagglutinin-stimulated lymphoblasts. These results indicate that a therapeutic strategy based upon IFN-beta transduction of CD4+ T cells may be an approach to controlling a preexisting HIV infection and allowing immune restoration.


* Corresponding author. Mailing address: Laboratoire d'Immunologie Cellulaire et Tissulaire, UMR CNRS 7627, Hopital Pitie-Salpêtrière, 83 Blvd. de l'Hôpital, 75013 Paris, France. Phone: 33-1-42-17-74-03. Fax: 33-1-42-17-74-90. E-mail: brigitte.autran{at}psl.ap-hop-paris.fr.

dagger Present address: Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138.


Journal of Virology, December 1999, p. 10281-10288, Vol. 73, No. 12
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hosmalin, A., Lebon, P. (2006). Type I interferon production in HIV-infected patients. J. Leukoc. Biol. 80: 984-993 [Abstract] [Full Text]  
  • Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A., Liu, Y.-J. (2001). Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98: 906-912 [Abstract] [Full Text]  
  • Chen, Z. W., Shen, Y., Zhou, D., Simon, M., Kou, Z., Lee-Parritz, D., Shen, L., Sehgal, P., Letvin, N. L. (2001). In Vivo T-Lymphocyte Activation and Transient Reduction of Viral Replication in Macaques Infected with Simian Immunodeficiency Virus. J. Virol. 75: 4713-4720 [Abstract] [Full Text]  
  • Lever, A M L (2001). Gene therapy for HIV. Sex. Transm. Infect. 77: 93-96 [Full Text]  
  • Matheux, F., Lauret, E., Rousseau, V., Larghero, J., Boson, B., Vaslin, B., Cheret, A., De Maeyer, E., Dormont, D., LeGrand, R. (2000). Simian immunodeficiency virus resistance of macaques infused with interferon {beta}-engineered lymphocytes. J. Gen. Virol. 81: 2741-2750 [Abstract] [Full Text]